| Literature DB >> 30528349 |
Eliana Marisa Ramos1, Christos Koros2, Deepika Reddy Dokuru1, Victoria Van Berlo1, Christos Kroupis3, Kevin Wojta1, Qing Wang1, Nikolaos Andronas2, Stavroula Matsi2, Ion N Beratis2, Alden Y Huang4, Suzee E Lee5, Anastasios Bonakis2, Chryseis Florou-Hatziyiannidou3, Stella Fragkiadaki2, Dionysia Kontaxopoulou2, Dimitrios Agiomyrgiannakis6, Vasiliki Kamtsadeli6, Niki Tsinia6, Vasiliki Papastefanopoulou7, Maria Stamelou8, Bruce L Miller5, Leonidas Stefanis9, John D Papatriantafyllou6, Sokratis G Papageorgiou2, Giovanni Coppola10.
Abstract
Frontotemporal dementia (FTD) is a heterogeneous group of neurodegenerative syndromes associated with several causative and susceptibility genes. Herein, we aimed to determine the incidence of the most common causative dementia genes in a cohort of 118 unrelated Greek FTD spectrum patients. We also screened for novel possible disease-associated variants in additional 21 genes associated with FTD or amyotrophic lateral sclerosis. Pathogenic or likely pathogenic variants were identified in 16 cases (13.6%). These included repeat expansions in C9orf72 and loss-of-function GRN variants, and likely pathogenic variants in TARDBP, MAPT, and PSEN1. We also identified 14 variants of unknown significance in other rarer FTD or amyotrophic lateral sclerosis genes that require further segregation and functional analysis. Our genetic screen revealed a high genetic burden in familial Greek FTD cases (30.4%), whereas only two of the sporadic cases (3.5%) carried a likely pathogenic variant. A substantial number of familial cases still remain without an obvious causal variant, suggesting the existence of other FTD genetic causes besides those currently screened in clinical routine.Entities:
Keywords: C9orf72; Frontotemporal dementia; GRN; Greece
Mesh:
Substances:
Year: 2018 PMID: 30528349 PMCID: PMC6553875 DOI: 10.1016/j.neurobiolaging.2018.10.029
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673